OTL Newsletters: THE UNVARNISHED TRUTH
Jeffrey Werner takes a closer look at current topics related to Medicare in THE UNVARNISHED TRUTH, occasional newsletters from OTL Benefits covering topics that impact health coverage and costs for Medicare recipients.
If you would like to receive OTL Newsletters in your inbox, email jeff@otlbenefits.com or sign up using the form below.
Looking Forward To 2027 Medicare Advantage Offerings
Medicare Advantage plans provide coverage for 55% of the nation’s Medicare population and rely on reimbursements from the Federal government. Earlier this year, the Federal government released 2027 reimbursement estimates at less than 1% increase.
Forecasting 2025? It's a challenge!
My goal is to attempt to explain the forces at play with our plans as we look to 2025. I have two items of concern – recent news about Federal reimbursements to Medicare Advantage insurers and, going back to my last newsletter, the $2000 annual cap on out-of-pocket prescription costs.
Lower Prescription Drug Costs For Seniors Come From Biden Administration
This year, I spent a great deal of time helping clients deal with the cost of prescription drugs. Which prescriptions were costing Medicare enrollees the most? One way to answer that question is to review a list of drugs that cost Medicare the most money.
Compass Medical Group Closes, Approval of Alzheimer's Drugs
The Unvarnished Truth is an occasional newsletter that covers news and topics of interest for those of us approaching or enrolled in Medicare. I will cover two important items in this edition: My first item is Compass Medical Group, which announced last Wednesday night that it would be closing its practices, effective immediately.